Patents by Inventor Rakesh Bhat

Rakesh Bhat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT CARDIOMYOCYTES AND CARDIOMYOCYTE CELL LINES EXPRESSING HERG
    Publication number: 20230235290
    Abstract: The present disclosure relates generally to recombinant cardiomyocytes and cardiomyocyte cell lines overexpressing hERG and uses thereof.
    Type: Application
    Filed: February 2, 2023
    Publication date: July 27, 2023
    Inventors: Rakesh BHAT, Michael HOUGHTON
  • Recombinant cardiomyocytes and cardiomyocyte cell lines expressing hERG
    Patent number: 11591570
    Abstract: Provided herein are recombinant cardiomyocytes and cardiomyocyte cell lines expressing human Ether-a-go-go Related Gene (hERG) potassium ion channel, including, for example, stable cell lines, that comprise a transfected or transduced nucleic acid sequence encoding hERG. Also provided herein are methods of using the recombinant cardiomyocytes and cardiomyocyte cell lines expressing hERG for screening compounds for cardiotoxicity, including methods for determining the activity of compounds to inhibit hERG.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: February 28, 2023
    Assignee: The Governors of the University of Alberta
    Inventors: Rakesh Bhat, Michael Houghton
  • RECOMBINANT CARDIOMYOCYTES AND CARDIOMYOCYTE CELL LINES EXPRESSING HERG
    Publication number: 20200181577
    Abstract: The present disclosure relates generally to recombinant cardiomyocytes and cardiomyocyte cell lines overexpressing hERG and uses thereof.
    Type: Application
    Filed: September 13, 2017
    Publication date: June 11, 2020
    Applicant: The Governors of the University of Alberta
    Inventors: Rakesh Bhat, Michael Houghton